文献速递神经肿瘤

前瞻性临床试验中原发性脑肿瘤患者放疗前多领域神经认知分类

Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial.
PubMed 文献 · J Neurooncol · 2019-11-23

该前瞻性试验对37例原发性脑肿瘤患者在放疗前及放疗后3、6、12个月进行多领域神经心理测试,发现记忆和执行功能损害最常见,基线整体缺陷评分与肿瘤体积、肿瘤类型、癫痫史及抗癫痫药使用相关,基线GDS可识别认知损害风险。

要点

  • 放疗前记忆和执行功能损害最常见。
  • 基线GDS与肿瘤体积、类型、癫痫史及抗癫痫药使用相关。
  • 基线GDS可识别认知损害风险。

核心结论

  • 放疗前记忆和执行功能损害是最常见的认知缺陷,较大肿瘤、更具侵袭性组织学及使用抗癫痫药的患者基线GDS更高,GDS是涵盖多领域神经认知功能的有前景工具,基线GDS可识别认知损害风险。

研究设计与样本

  • 前瞻性临床试验,对37例原发性脑肿瘤患者在放疗前及放疗后3个月(n=21)、6个月(n=22)、12个月(n=14)进行多领域神经心理测试(记忆、执行功能、语言、注意、处理速度)。

主要发现

  • 基线时4项记忆测试(均p≤0.03)和3项执行功能测试中的2项(p=0.01,p=0.027)存在统计学显著的神经认知损害。
  • 患者基线GDS与肿瘤体积(p=0.048)、肿瘤类型(p=0.043)、癫痫史(p=0.007)及抗癫痫药使用(p=0.009)显著相关。
  • 3、6、12个月时与基线损害状态相同的患者比例分别为88%、85%、85%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We investigated multi-domain baseline neurocognition of primary brain tumor patients prior to radiotherapy (RT), including clinical predictors of function and association between pre-RT and post-RT impairment on a prospective trial. METHODS: A multi-domain neuropsychological battery (memory, executive functioning, language, attention, processing) was performed on 37 patients, pre-RT and 3-(n = 21), 6-(n = 22) and 12-(n = 14) months post-RT. Impairment rate was the proportion of patients with standardized T-scores ≤ 1.5 standard deviations below normative means. Per-patient impairment across all domains was calculated using a global deficit score (GDS; higher value indicates more impairment). Associations between baseline GDS and clinical variables were tested. Global GDS impairment rate at each time point was the fraction of patients with GDS scores > 0.5. RESULTS: Statistically significant baseline neurocognitive impairments were identified on 4 memory (all p ≤ 0.03) and 2 out of 3 (p = 0.01, p = 0.027) executive functioning tests. Per-patient baseline GDS was significantly associated with tumor volume (p = 0.048), tumor type (p = 0.043), seizure history (p = 0.007), and use of anti-epileptics (p = 0.009). The percentage of patients with the same impairment status at 3-, 6-, and 12-months as at baseline were 88%, 85%, and 85% respectively. CONCLUSIONS: Memory and executive functioning impairment were the most common cognitive deficits prior to RT. Patients with larger tumors, more aggressive histology, and use of anti-epileptics had higher baseline GDS values. GDS is a promising tool to encompass multi-domain neurocognitive function, and baseline GDS can identify those at risk of cognitive impairment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Karunamuni R, Tringale KR, Burkeen J, et al. Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial. J Neurooncol. 2019. PMID: 31760596. doi:10.1007/s11060-019-03353-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。